{"database": "lobbying", "table": "lobbying_activities", "rows": [[588691, "d4f87e7b-fb12-4de8-9909-8fac4f606b30", "Q1", "DALRYMPLE & ASSOCIATES, LLC", 5073, "EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION)", 2008, "first_quarter", "HOM", "Anthrax vaccine and anthrax immune globulin research, acquisition and immunization funding, legislation, appropriations, and oversight.", null, 45000, null, 0, 0, "2008-04-14T13:47:10-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["588691"], "units": {}, "query_ms": 0.4467940016184002, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}